Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Driven by 5 papers. Top paper: “Phase II, randomised, double-blind, multicentre study evaluating the safety and efficacy of filgotinib and lanraplenib in patients with lupus membranous nephropathy”.
Yashaar Chaichian, Mark C. Genovese, Vimal K. Derebail, Panduranga S. Rao, Winn Chatham +7 more
Wolfgang C. Winkelmayer, Alexandru Costea, Prabir Roy‐Chaudhury, James A. Tumlin, Vijay Kher +51 more
Huijuan Song, Haikady N. Nagaraja, J. Allen Scott, Jessica Greco, Xiaolan Zhang +6 more
Parker Lopez, Julie Sullivan, Jeremy Whitson, James A. Tumlin, Erika A. Tyburski +2 more
Brad H. Rovin, Hans‐Joachim Anders, Eduardo Mysler, David Jayne, Tsutomu Takeuchi +6 more